/ Print /

LATEST

Five things to know about Trump’s FDA lead pick GottliebOn March 10, the White House announced that President Donald Trump selected Scott Gottlieb, MD, who has worked for FDA in the past, as his choice to head the FDA. Here are five things managed healthcare executives should know about the pick.
Opinion: More industry-stakeholders play blame game for high drug costsOur policy analyst weighs in on a new drug industry PR campaign that attempts to shift the blame for high drug costs.
How to target high-risk populations with behavioral healthHere are four of the top benefits of incorporating behavioral health management into care management plans for members with chronic conditions.
Start MACRA reporting with a HIPAA risk assessment, or don’t start at allHere are five key security risk assessment elements to identify and remediate.
Senior housing, healthcare partnership leads to savings, lower readmissionsPartnership between senior living provider and healthcare system improves population health.
Inaccurate provider directories create barriers to careHere are four ways that health plans can improve their internal processes for collecting provider data.
What more transparency at the FDA means for health executivesResearchers create a set of recommendations for transparency at the agency in five principal areas.
Five pharmacy regulations health execs must keep on their radars in 2017Here are five critical regulations that executives can begin to prepare for today.
Prepare providers for telemedicine: 3 critical training areasTo ensure providers are prepared for telemedicine practice, healthcare leaders must provide training in these areas.
Strategic planning amidst uncertainty: 10 considerations for health execsHealthcare leaders are concerned about developing reliable strategies for the future. Is effective strategic and financial planning even possible with so many variables up in the air?